SCHEMBL31639751

SCHEMBL31639751

Cc1nc(-c2c(-c3nn(C(C)(C)C)c4ncnc(N)c34)noc2C2CC2)ncc1C1CCNCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 10/20 0.39
▸ SRC P12931 10/20 0.39
▸ KDR P35968 6/20 0.39
▸ ABL1 P00519 6/20 0.39
▸ RIPK2 O43353 3/20 0.39
▸ FYN P06241 3/20 0.39
▸ CSNK1D P48730 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ EGFR P00533 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ LCK P06239 2/20 0.39
▸ YES1 P07947 2/20 0.39
▸ LYN P07948 2/20 0.39
▸ PDGFRA P16234 2/20 0.39
▸ PRKACA P17612 2/20 0.39
▸ FRK P42685 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ MAPK9 P45984 2/20 0.39
▸ CSNK1A1 P48729 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31640038 0.93 RET (0.40) RETSRCKDRABL1RIPK2
SCHEMBL31639568 0.89 RET (0.43) RETSRCKDRABL1RIPK2
Hydrochloric Acid SCHEMBL31639825 0.88 SRC (0.43) RETSRCKDRABL1RIPK2
SCHEMBL31639658 0.88 RET (0.38) RETSRCKDRABL1RIPK2
SCHEMBL31641098 0.87 RET (0.49) RETKDRRPS6KB1FLT4CYP1A2
SCHEMBL31640331 0.86 RET (0.42) RETSRCKDRABL1RIPK2
SCHEMBL31639980 0.86 SRC (0.42) RETSRCKDRABL1RIPK2
SCHEMBL31639828 0.85 TGFBR1 (0.39) RETSRCKDRABL1RIPK2
SCHEMBL31639614 0.83 RET (0.44) RETSRCKDRABL1RIPK2
SCHEMBL31640604 0.83 RET (0.47) RETKDRRPS6KB1FLT4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137605-A1 COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR C4 THERAPEUTICS, INC. (US) 2025-06-26 — — WO disclosed
Send feedback